<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[biotechnology Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/biotechnology.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to biotechnology]]></description>
	<s:counts start="0" returned="20" found="6419" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Bankers Reveal Top Biotech IPO Contenders; New Filer Ironwood Among Them]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005484/bankers-reveal-top-biotech-ipo-contenders-new-filer-ironwood-among-them/]]></link>
		<description><![CDATA[Ironwood Pharmaceuticals filed for an initial public offering today, a move that several biotech investors had previously predicted. Here are the other names topping their likely-filer list. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 23 Nov 2009 20:56:55 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Bring Me the Head of Genzyme CEO Henri Termeer!]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005350/bring-me-the-head-of-genzyme-ceo-henri-termeer/]]></link>
		<description><![CDATA[How long will it be before Genzyme GENZ CEO Henri Termeer resigns? That question was asked openly at TheStreet.com, which named Termeer the worst Biotech CEO of 2009. A change of management at Genzyme is increasingly likely now that investor Carl Icahn has upped his stake in the company. by...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 17 Nov 2009 10:37:20 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/ceo.html"><![CDATA[CEO]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="tickers">GENZ</category>
	</item>
	<item>
		<title><![CDATA[Microsoft Co-founder Allen Diagnosed With Cancer]]></title>
		<link><![CDATA[http://www.bnet.com/2407-14061_23-365525.html]]></link>
		<description><![CDATA[SAN FRANCISCO (<a href="http://resources.bnet.com/index.php?source=Reuters">Reuters</a>) - Microsoft Corp co-founder Paul Allen has been diagnosed with non-Hodgkin's lymphoma and has begun treatment, a spokesman for his investment company said on Monday.Employees of Vulcan Inc, which Allen formed in 1986 to manage his business dealings and philanthropic activity, were informed of Allen's illness in...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Tue, 17 Nov 2009 05:01:44 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/paul+allen.html"><![CDATA[Paul Allen]]></category>
		<category domain="http://resources.bnet.com/topic/microsoft+corp..html"><![CDATA[Microsoft Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/team+management.html"><![CDATA[Team Management]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/financial+services.html"><![CDATA[Financial Services]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/us.html"><![CDATA[Us]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MSFT</category>
		<category domain="tickers">MSFT</category>
	</item>
	<item>
		<title><![CDATA[Microsoft Co-founder Diagnosed With Cancer]]></title>
		<link><![CDATA[http://www.bnet.com/2407-14061_23-365610.html]]></link>
		<description><![CDATA[SAN FRANCISCO (<a href="http://resources.bnet.com/index.php?source=ReutersUK">Reuters UK</a>) - Microsoft Corp co-founder Paul Allen has been diagnosed with non-Hodgkin's lymphoma and has begun treatment, a spokesman for his investment company said on Monday.Employees of Vulcan Inc, which Allen formed in 1986 to manage his business dealings and philanthropic activity, were informed of Allen's illness...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Mon, 16 Nov 2009 23:01:06 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/paul+allen.html"><![CDATA[Paul Allen]]></category>
		<category domain="http://resources.bnet.com/topic/microsoft+corp..html"><![CDATA[Microsoft Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/team+management.html"><![CDATA[Team Management]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/financial+services.html"><![CDATA[Financial Services]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/oukbs.html"><![CDATA[Oukbs]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MSFT</category>
		<category domain="tickers">MSFT</category>
	</item>
	<item>
		<title><![CDATA[What Genentech and Roche Got From Congress for $15M]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005311/what-genentech-and-roche-got-from-congress-for-15m/]]></link>
		<description><![CDATA[Genentech and its parent, Roche (RHHBY.PK), paid lobbyists nearly $15 million in 2008 and 2009 as they urged Congressmen to support the biotech industry's interests in the healthcare bill and other legislation. The result, chronicled in the New York Times, is that 42 members of the U.S. House of Representatives...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 15 Nov 2009 08:18:05 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+congress.html"><![CDATA[U.S. Congress]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="tickers">DNA</category>
	</item>
	<item>
		<title><![CDATA[Scandal Provides Another Reason Omeros Might Not Be the Biotech IPO Bellwether]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005233/scandal-provides-another-reason-omeros-might-not-be-the-biotech-ipo-bellwether/]]></link>
		<description><![CDATA[Omeros Corp.'s recent IPO flop may be due to factors other than a lack of investor appetite for the biotech sector: the company is embroiled in a wrongful termination lawsuit with claims of defrauding the NIH and lying about taxes. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 10 Nov 2009 20:17:52 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/termination.html"><![CDATA[Termination]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/workforce+management.html"><![CDATA[Workforce Management]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Despite Omeros Flop, Trius and Other Biotech IPO Hopefuls Might Fare Better]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005194/despite-omeros-flop-trius-and-other-biotech-ipo-hopefuls-might-fare-better/]]></link>
		<description><![CDATA[Trius Therapeutics added its name to the initial public offering queue on Friday, apparently undeterred by the abysmal performance of Omeros Corp., the first true biotech to go public in the current IPO window. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 08 Nov 2009 20:45:13 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/ipo.html"><![CDATA[IPO]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/financial+planning.html"><![CDATA[Financial Planning]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/financial+services.html"><![CDATA[Financial Services]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Sangamo Biosciences, Inc. Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-361132.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator Instructions. First up is Charles Duncan, JMP Securities. Charles Duncan - JMP Securities My first question is regarding the Sigma or the traction Sigma is getting, Edward I was at site for neuroscience and there was a surprise out of that, and then I...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 04 Nov 2009 17:10:22 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/sangamo+biosciences+inc..html"><![CDATA[Sangamo BioSciences Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sigma.html"><![CDATA[Sigma]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGMO</category>
		<category domain="tickers">SGMO</category>
	</item>
	<item>
		<title><![CDATA[Pfizer Demands DNA of Trovan Victims Who Are Owed Compensation]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005088/pfizer-demands-dna-of-trovan-victims-who-are-owed-compensation/]]></link>
		<description><![CDATA[Victims covered by Pfizer's $75 million settlement of the Trovan meningitis case in Nigeria must produce DNA tests before they will receive their part of the payout, according to This Day, an African news web site. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 02 Nov 2009 15:09:46 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/compensation.html"><![CDATA[Compensation]]></category>
		<category domain="http://resources.bnet.com/topic/dna.html"><![CDATA[DNA]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Why Biogen Idec Is Likely to Flinch Before Facet Biotech in Their Game of Chicken]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005023/why-biogen-idec-is-likely-to-flinch-before-facet-biotech-in-their-game-of-chicken/]]></link>
		<description><![CDATA[Biogen Idec's attempted hostile takeover of Facet Biotech, its partner on the potential blockbuster multiple sclerosis drug daclizumab, isn't going according to plan. And the snippy back-and-forths between the two companies are starting to ring with desperation. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 26 Oct 2009 22:18:40 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biogen+idec+inc..html"><![CDATA[Biogen Idec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/games.html"><![CDATA[Games]]></category>
		<category domain="http://resources.bnet.com/topic/personal+technology.html"><![CDATA[Personal Technology]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
		<category domain="tickers">BIIB</category>
	</item>
	<item>
		<title><![CDATA[Visible Technologies Gets Funding To Help The CIA Monitor Social Media]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fpaidcontent.org%2Farticle%2F419-visible-technologies-gets-funding-to-help-the-cia-monitor-social-media%2F&siteid=23&tag=contentnext]]></link>
		<description><![CDATA[ As if posting a stream of status updates to hundreds of strangers on Twitter doesn&#8217;t have enough &#8220;big brother&#8221; potential ... Visible Technologies, the WPP-backed social media monitoring firm, has picked up an undisclosed amount of funding from In-Q-Tel, the strategic investment arm of the U.S. government. In-Q-Tel serves...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 20 Oct 2009 22:54:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cia.html"><![CDATA[CIA]]></category>
		<category domain="http://resources.bnet.com/topic/twitter+inc..html"><![CDATA[Twitter Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/social+media.html"><![CDATA[Social Media]]></category>
		<category domain="http://resources.bnet.com/topic/in-q-tel.html"><![CDATA[In-Q-Tel]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+insurance.html"><![CDATA[Corporate Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/software+development.html"><![CDATA[Software Development]]></category>
		<category domain="http://resources.bnet.com/topic/homeland+security.html"><![CDATA[Homeland Security]]></category>
		<category domain="http://resources.bnet.com/topic/business+security.html"><![CDATA[Business Security]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/branding.html"><![CDATA[Branding]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/software%252fweb+development.html"><![CDATA[Software/Web Development]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/money.html"><![CDATA[Money]]></category>
		<category domain="http://resources.bnet.com/topic/m%2526a+%2526+venture+capital.html"><![CDATA[M&A & Venture Capital]]></category>
		<category domain="http://resources.bnet.com/topic/venture+capital.html"><![CDATA[Venture Capital]]></category>
		<category domain="http://resources.bnet.com/topic/technologies+%252f+formats.html"><![CDATA[Technologies / Formats]]></category>
		<category domain="http://resources.bnet.com/topic/tameka+kee.html"><![CDATA[Tameka Kee]]></category>
	</item>
	<item>
		<title><![CDATA[How NOT to Write a Biotech Press Release: Just Ask Epeius]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004877/how-not-to-write-a-biotech-press-release-just-ask-epeius/]]></link>
		<description><![CDATA[If there is one cardinal sin in biotech communications, it is hype. Telling late-night TV viewers youâ€™ve made a miracle toaster is one thing; telling desperate and dying patients youâ€™ve made a miracle cancer drug is quite another. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 18 Oct 2009 20:26:26 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[UK Biotech Gets a Big Boost from GSK]]></title>
		<link><![CDATA[http://blogs.bnet.co.uk/sterling-performance/2009/10/13/uk-biotech-gets-a-big-boost-from-gsk/]]></link>
		<description><![CDATA[Big pharma proves a persuasive backer as the UK government announces a Â£37m investment in a biotech campus on the GlaxoSmithKline R&D site. by Joanna Higgins]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 13 Oct 2009 12:24:53 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/uk+biotech.html"><![CDATA[UK Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/joanna+higgins.html"><![CDATA[Joanna Higgins]]></category>
	</item>
	<item>
		<title><![CDATA[Google Ventures Invests In English Language Learning Startup EnglishCentral]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fpaidcontent.org%2Farticle%2F419-google-ventures-invests-in-english-language-learning-startup-englishcen%2F&siteid=23&tag=contentnext]]></link>
		<description><![CDATA[ An active week for Google&#8217;s venture capital arm. On Thursday, Google Ventures was the lead investor in a round of funding for biotech startup Adimab, and it&#8217;s now also listed as an investor in online English language learning company EnglishCentral. The startup says it raised an undisclosed seed round...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 02 Oct 2009 15:14:35 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/google+inc..html"><![CDATA[Google Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[Investor]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/money.html"><![CDATA[Money]]></category>
		<category domain="http://resources.bnet.com/topic/m%2526a+%2526+venture+capital.html"><![CDATA[M&A & Venture Capital]]></category>
		<category domain="http://resources.bnet.com/topic/venture+capital.html"><![CDATA[Venture Capital]]></category>
		<category domain="http://resources.bnet.com/topic/social+media.html"><![CDATA[Social Media]]></category>
		<category domain="http://resources.bnet.com/topic/video.html"><![CDATA[Video]]></category>
		<category domain="http://resources.bnet.com/topic/companies.html"><![CDATA[Companies]]></category>
		<category domain="http://resources.bnet.com/topic/google.html"><![CDATA[Google]]></category>
		<category domain="http://resources.bnet.com/topic/joseph+tartakoff.html"><![CDATA[Joseph Tartakoff]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
		<category domain="tickers">GOOG</category>
	</item>
	<item>
		<title><![CDATA[War Stories I: Turnaround Takes MDRNA from Two Weeks of Cash to Seven Deals]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004471/war-stories-i-turnaround-takes-mdrna-from-two-weeks-of-cash-to-seven-deals/]]></link>
		<description><![CDATA[At the recent BioPharm America conference in San Francisco, biotech CEOs and investors swapped war stories - including this one about how MDRNA made it back from the brink. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 27 Sep 2009 22:10:20 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/story.html"><![CDATA[Story]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Who's Afraid of Big, Bad Cardiovascular? Apparently Not Biotech...]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004465/whos-afraid-of-big-bad-cardiovascular-apparently-not-biotech/]]></link>
		<description><![CDATA[Cardiovascular disease brings to mind huge, expensive clinical trials and huge, expensive primary care sales forcesâ€¦but not necessarily huge, expensive drug prices. With the basics of cholesterol management met, some big pharmas are turning away from the field, but enterprising biotechs are stepping in. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 24 Sep 2009 16:19:53 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cholesterol.html"><![CDATA[Cholesterol]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Biotech Fundraising Options for Those With No Options]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004395/biotech-fundraising-options-for-those-with-no-options/]]></link>
		<description><![CDATA[Yes, the financing climate appears to be thawing, and for those with good data, itâ€™s been positively hot. But there are still plenty of biotechs being forced to get creative with their fundraising efforts. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 21 Sep 2009 20:00:27 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/financing.html"><![CDATA[Financing]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[What Fool Will Buy the Talecris IPO? Oh Wait, That'll Be Me.]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004389/what-fool-will-buy-the-talecris-ipo-oh-wait-thatll-be-me/]]></link>
		<description><![CDATA[Itâ€™s hard to imagine why anyone would want to buy a piece of Talecris Biotherapeuticsâ€™ proposed $850 million initial public offering.    VentureBeat said it best when Talecris tried to go public two years ago:  So what we have is a profitable but relatively slow-growing biotech with...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 20 Sep 2009 20:00:02 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/talecris+biotherapeutics.html"><![CDATA[Talecris Biotherapeutics]]></category>
		<category domain="http://resources.bnet.com/topic/ipo.html"><![CDATA[IPO]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/financial+planning.html"><![CDATA[Financial Planning]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/financial+services.html"><![CDATA[Financial Services]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[NextBio Raises $8 Million For Life Sciences Search Engine]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fpaidcontent.org%2Farticle%2F419-nextbio-raises-8-million-for-life-sciences-search-engine%2F&siteid=23&tag=contentnext]]></link>
		<description><![CDATA[ NextBio has raised $8 million in a third round of funding led by Newbury Ventures. NextBio&#8217;s search engine lets anyone search for scientific literature, clinical trials, and scientific news by pulling results from various public databases (Example queries: &#8220;DNA fingerprint,&#8221; &#8220;IGF1,&#8221; &#8220;Response to oxidative stress&#8221;). NextBio also has specialized...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 18 Sep 2009 18:20:21 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/nextbio.html"><![CDATA[NextBio]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/media+%2526+publishing.html"><![CDATA[Media & Publishing]]></category>
		<category domain="http://resources.bnet.com/topic/health+content.html"><![CDATA[Health Content]]></category>
		<category domain="http://resources.bnet.com/topic/search.html"><![CDATA[Search]]></category>
		<category domain="http://resources.bnet.com/topic/money.html"><![CDATA[Money]]></category>
		<category domain="http://resources.bnet.com/topic/m%2526a+%2526+venture+capital.html"><![CDATA[M&A & Venture Capital]]></category>
		<category domain="http://resources.bnet.com/topic/venture+capital.html"><![CDATA[Venture Capital]]></category>
		<category domain="http://resources.bnet.com/topic/joseph+tartakoff.html"><![CDATA[Joseph Tartakoff]]></category>
	</item>
	<item>
		<title><![CDATA[Drama Runs in Facet Biotech's Family -- Just Ask Parent PDL BioPharma]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004162/drama-runs-in-facet-biotechs-family-just-ask-parent-pdl-biopharma/]]></link>
		<description><![CDATA[Biotech is no stranger to contentious negotiations with potential acquirers, or activist investors demanding liquidation, or product failures, or reorganizations, or patent fights. But PDL BioPharma has to be wondering: why does everything happen to us? by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 08 Sep 2009 21:50:40 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
</channel>
</rss>
